03:05:47 EDT Sat 27 Jul 2024
Enter Symbol
or Name
USA
CA



E:CYBN - CYBIN INC. - http://www.cybin.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYBN - E  9.00.375·0.412.00.39+0.0051.3232.4831440.40  0.40  0.3850.98  0.3116:18:20Jul 0815 min RT 2¢
NEO exchange - E9.00.375·0.412.00.39+0.0051.3217.380860.40  0.40  0.3850.98  0.3116:18:2015 min
Omega - O 0.39+0.0051.33.5130.40  0.40  0.3915:16:5715 min
Chi-X - X 0.39+0.0051.36.0280.40  0.40  0.38515:39:0415 min
CX2 - H 0.40+0.0153.90.5010.40  0.40  0.4012:01:0315 min
CXD - D 0.3850.89    Jul 2315 min
TriAct - M 0.3854.2137    15 min

Recent Trades - Last 10 of 144
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:18:20E0.390.0050301 NEO Buy301 NEO BuyZ
15:59:30E0.390.0053,50079 CIBC1 AnonymousK
15:39:38M0.3950.01280 National Bank80 National BankE
15:39:15E0.390.0051,00084 ITG8413 InstinetK
15:39:12E0.390.0052,5009 BMO Nesbitt13 InstinetK
15:39:04E0.390.0051,5009 BMO Nesbitt1 AnonymousK
15:39:04X0.390.0055009 BMO Nesbitt39 Merrill LynchK
15:39:04E0.390.0052,5009 BMO Nesbitt79 CIBCK
15:39:04E0.390.0053,0009 BMO Nesbitt39 Merrill LynchK
15:38:37X0.390.00550084 ITG8439 Merrill LynchK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-06-26 15:29C:CYBN0.34News ReleaseCybin ends fiscal 2024 with cash of $209-million
2024-06-26 07:40C:CYBN0.36SEDAR MD & ASEDAR MD & A
2024-06-26 07:33C:CYBN0.36SEDAR Annual Information FormSEDAR Annual Information Form
2024-06-26 07:33C:CYBN0.36SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-06-19 07:30C:CYBN0.365News ReleaseCybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
2024-06-11 10:54C:CYBN0.385News ReleaseCybin appoints Mahableshwarkar SVP, clinic development
2024-05-30 14:26C:CYBN0.465News ReleaseNuminus to host Cybin trial on CYB003 at Cedar Clinical
2024-05-06 14:09C:CYBN0.485News ReleaseCybin reviews recent CYB003 activities
2024-04-18 13:00C:CYBN0.51News ReleaseCybin publishes CYB210010 research manuscript
2024-04-16 12:27C:CYBN0.51News ReleaseCybin receives depressive disorder therapy patent
2024-04-08 07:12C:CYBN0.55In the NewsGlobe says MindMed, Cybin get nod from U.S. FDA
2024-03-19 12:42C:CYBN0.61News ReleaseCybin closes $150-million (U.S.) private placement
2024-03-15 09:12C:CYBN0.61News ReleaseCybin begins phase 2 CYB004 study for GAD treatment
2024-03-14 11:30C:CYBN0.58News ReleaseCybin talks CYB003 phase 2 FDA meeting, phase 3 design
2024-03-13 09:16C:CYBN0.58News ReleaseCybin arranges $150-million (U.S.) private placement
2024-03-13 08:59C:CYBN0.57News ReleaseCybin's CYB003 receives FDA breakthrough designation
2024-03-12 23:17C:CYBN0.58News ReleaseCybin to host call March 13 for CYB003 update
2024-02-14 12:40C:CYBN0.475News ReleaseCybin has cash of $39-million at Dec. 31
2024-02-14 07:40C:CYBN0.475SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-14 07:34C:CYBN0.475SEDAR Interim Financial StatementsSEDAR Interim Financial Statements